These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 35768485)
1. Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma. Yin Z; Zhou M; Liao T; Xu J; Fan J; Deng J; Jin Y Front Oncol; 2021; 11():673567. PubMed ID: 35083132 [TBL] [Abstract][Full Text] [Related]
2. Exploration of the prognostic prediction value of the PANoptosis-based risk score and its correlation with tumor immunity in lung adenocarcinoma. Zhao X; Zhang X; Li F; Lu C J Gene Med; 2024 Mar; 26(3):e3682. PubMed ID: 38508210 [TBL] [Abstract][Full Text] [Related]
3. Identification and verification of a PANoptosis-related long noncoding ribonucleic acid signature for predicting the clinical outcomes and immune landscape in lung adenocarcinoma. Bao L; Ye Y; Zhang X; Xu X; Wang W; Jiang B Heliyon; 2024 Apr; 10(8):e29869. PubMed ID: 38681588 [TBL] [Abstract][Full Text] [Related]
4. Risk coefficient model of necroptosis-related lncRNA in predicting the prognosis of patients with lung adenocarcinoma. Chen H; Xie Z; Li Q; Qu G; Tan N; Zhang Y Sci Rep; 2022 Jun; 12(1):11005. PubMed ID: 35768485 [TBL] [Abstract][Full Text] [Related]
5. A risk stratification and prognostic prediction model for lung adenocarcinoma based on aging-related lncRNA. Chen H; Peng L; Zhou D; Tan N; Qu G Sci Rep; 2023 Jan; 13(1):460. PubMed ID: 36627319 [TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of a Novel Necroptosis-Related Long Noncoding RNA Prognostic Signature for Lung Adenocarcinoma. Zeng C; Yu H; Liu X; Liu Q; Jin J Biomed Res Int; 2022; 2022():9710540. PubMed ID: 36330457 [TBL] [Abstract][Full Text] [Related]
7. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma. Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S Front Genet; 2022; 13():862741. PubMed ID: 35368663 [No Abstract] [Full Text] [Related]
8. Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer. Liu Y; Hao H; Kang L; Zheng G; Guo X; Li B; Zhao H; Hao H BMC Gastroenterol; 2022 Jul; 22(1):345. PubMed ID: 35840890 [TBL] [Abstract][Full Text] [Related]
9. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma]. Zhou J; Wang X; Li Z; Jiang R Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900 [TBL] [Abstract][Full Text] [Related]
10. Identification of an Autophagy-Related lncRNA Prognostic Signature and Related Tumor Immunity Research in Lung Adenocarcinoma. Chen H; Hu Z; Sang M; Ni S; Lin Y; Wu C; Mu Y; Liu K; Wu S; Li N; Xu G Front Genet; 2021; 12():767694. PubMed ID: 34956321 [TBL] [Abstract][Full Text] [Related]
11. Identification and Validation a Necroptosis‑related Prognostic Signature and Associated Regulatory Axis in Stomach Adenocarcinoma. Wang N; Liu D Onco Targets Ther; 2021; 14():5373-5383. PubMed ID: 34880629 [TBL] [Abstract][Full Text] [Related]
12. Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer. Zhao Z; Liu H; Zhou X; Fang D; Ou X; Ye J; Peng J; Xu J J Oncol; 2021; 2021():6718443. PubMed ID: 34790235 [TBL] [Abstract][Full Text] [Related]
13. A Five Autophagy-Related Long Non-Coding RNA Prognostic Model for Patients with Lung Adenocarcinoma. Liu B; Yang S Int J Gen Med; 2021; 14():7145-7158. PubMed ID: 34737609 [TBL] [Abstract][Full Text] [Related]